Response to Comment on “Tacrolimus Drug-Drug Interaction with Nirmatrelvir/Ritonavir (Paxlovid™) Managed with Phenytoin”

被引：0
|
作者：
Morganne Sindelar
Daniel McCabe
Elisabeth Carroll
机构：
[1] The University of Iowa Hospitals & Clinics,Division of Medical Toxicology, Department of Emergency Medicine
[2] The University of Iowa Hospitals & Clinics,undefined
来源：
Journal of Medical Toxicology | 2023年 / 19卷
关键词：
Drug-drug interaction; Tacrolimus; Nirmatrelvir/ritonavir;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：309 / 309
相关论文
共 50 条
  • [41] Acute tacrolimus toxicity due to Paxlovid successfully managed with phenytoin
    White, C.
    Stephanie, B.
    Murnion, B.
    Plit, M.
    Darley, D.
    RESPIROLOGY, 2024, 29 : 224 - 224
  • [42] Evaluating Drug Interaction Risks: Nirmatrelvir & Ritonavir Combination (PAXLOVID®) with Concomitant Medications in Real-World Clinical Settings
    Zatovkanukova, Petra
    Vesely, Dalibor
    Sliva, Jiri
    PATHOGENS, 2024, 13 (12):
  • [43] Strategies to mitigate the drug-drug interaction between nirmatrelvir/ritonavir and tacrolimus in allogeneic hematopoietic stem cell transplant recipients on azole-antifungals: results of a case series
    Griffin, Shawn P.
    Lee, Benjamin
    Doh, Jean
    Paradyse, Alexander R.
    Jeyakumar, Deepa
    Arter, Zhaohui
    Nam, Hannah
    Blodget, Emily
    Smith, Julie
    Valek, Anitram
    Vittayawacharin, Pongthep
    Kongtim, Piyanuch
    Ciurea, Stefan O.
    ACTA HAEMATOLOGICA, 2023, : 371 - 377
  • [44] Paxlovid (Nirmatrelvir/Ritonavir)-Induced Tacrolimus Toxicity in Organ Transplant Recipients - A Review on Drug Interactions Involving CYP3A Enzymes
    Maideen, Naina Mohamed Pakkir
    Al Rashid, Sulthan
    CURRENT DRUG SAFETY, 2024,
  • [45] Overview of Drug-Drug Interactions Between Ritonavir-Boosted Nirmatrelvir (Paxlovid) and Targeted Therapy and Supportive Care for Lung Cancer (vol 4, 100452, 2023)
    不详
    JTO CLINICAL AND RESEARCH REPORTS, 2023, 4 (07):
  • [46] Management of potential drug-drug interactions with nirmatrelvir-ritonavir and oral anticoagulants: a case series
    Vazquez, Sara R.
    Wilson, Aaron S.
    Witt, Daniel M.
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2022, 54 (04) : 583 - 586
  • [47] MANAGEMENT OF POTENTIAL DRUG-DRUG INTERACTIONS WITH NIRMATRELVIR-RITONAVIR AND ORAL ANTICOAGULANTS: A CASE SERIES
    Wilson, Aaron S.
    Vazquez, Sara R.
    Witt, Daniel M.
    AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 : E120 - E120
  • [48] Characterization of nirmatrelvir-ritonavir (Paxlovid®) calls managed by a regional poison center
    Lam, Angela
    Yemets, Masha
    Couch, Denise
    Leonard, James
    CLINICAL TOXICOLOGY, 2023, 61 : 109 - 109
  • [49] Nirmatrelvir+ritonavir/tacrolimus/tozinameranIncrease tacrolimus drug level and vaccine failure: case report
    Reactions Weekly, 2022, 1918 (1) : 388 - 388
  • [50] Management of potential drug-drug interactions with nirmatrelvir-ritonavir and oral anticoagulants: a case series
    Sara R. Vazquez
    Aaron S. Wilson
    Daniel M. Witt
    Journal of Thrombosis and Thrombolysis, 2022, 54 : 583 - 586
12345